Biosimilar epoetins: an analysis based on recently implemented European medicines evaluation agency guidelines on comparability of biophamaceutical proteins

N. combe; R.L. Tredree; H. Schellekens

Biosimilar epoetins: an analysis based on recently implemented European medicines evaluation agency guidelines on comparability of biophamaceutical proteins

N. combe
, R.L. Tredree
, H. Schellekens

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	954-962
Number of pages	9
Journal	Pharmacotherapy
Volume	25
Issue number	7
Publication status	Published - 2005

Cite this

@article{e933506fac2948fd9450bcf6a8ef0532,

title = "Biosimilar epoetins: an analysis based on recently implemented European medicines evaluation agency guidelines on comparability of biophamaceutical proteins",

author = "N. combe and R.L. Tredree and H. Schellekens",

year = "2005",

language = "Undefined/Unknown",

volume = "25",

pages = "954--962",

journal = "Pharmacotherapy",

issn = "1875-9114",

publisher = "American College of Clinical Pharmacy",

number = "7",

}